Faruqi and Faruqui, LLP Logo
Share this page

Most Recent Cases

Page 53 of 54 (1062 Items)
13
Nov
2009

Rhodes v. National Collegiate Athletic Association, et al, No. 09-5378 (N.D. Cal.)

Faruqi & Faruqi represents a proposed class of Division 1 college athletes and former athletes against the NCAA and its licensing agent alleging conspiracy to preclude athletes from profiting from use of their images in violation of  § 1 of the Sherman Act.

15
Sep
2009

In re: Packaged Ice Antitrust Litigation, Case No. 08-MD-01952

Plaintiffs allege Defendants (Reddy Ice, Arctic Glacier, and Home City Ice), the three largest companies in the United States that manufacture and distribute packaged ice, conspired not to compete with each other in violation of the federal antitrust laws.

29
Jun
2009

Connecticut Children’s Medical Center v. Lundbeck, Inc., No. 09-1652 (D. Minn.)

Faruqi & Faruqi represented a class of direct purchasers of drugs Indocin and NeoProfen alleging monopolization under §§ 1 and 2 of the Sherman Act and § 7 of the Clayton Act. This case settled in 2011.

02
Jun
2009

In re Blood Reagents Antitrust Litigation, No. 09-2081 (E.D. Pa.)

In the Blood Reagents price fixing case, Faruqi & Faruqi represents a proposed class of direct purchasers of blood reagent products, challenging conspiracy to fix prices, in violation of § 1 of the Sherman Act.  Plaintiffs have alleged that defendants Immucor and Ortho-Clinics Diagnostics, a subsidiary of Johnson & Johnson,... READ MORE

01
Jun
2009

In re Delta/AirTran Baggage Fee Antitrust Litigation, No. 09-MD-2089 (N.D. Ga.)

Faruqi & Faruqi represents a proposed class of direct purchasers challenging conspiracy to fix baggage fees by two major airlines, in violation of § 1 of the Sherman Act.

03
Feb
2009

In re AndroGel Antitrust Litigation (II), 09-md-2084 (N.D. Ga.)

In the Androgel litigation, Faruqi & Faruqi, LLP represent a pharmaceutical wholesaler and a proposed class of direct purchasers of Abbott’s branded testosterone drug, AndroGel.  The case alleges that Abbott’s predecessor filed baseless patent litigation and entered a series of horizontal market allocation agreements with generic manufacturers Watson and Par/Paddock... READ MORE

09
Jan
2009

In re Online DVD Rental Antitrust Litigation, No. 09-2029 (N.D. Cal.)

Faruqi & Faruqi represents a class of subscribers to Netflix alleging a per se illegal market allocation agreement between it and Wal-Mart.  Plaintiffs alleged a scheme where Walmart agreed with Netflix to stay out of the DVD rental business in exchange for Netflix staying of the DVD sales business.  Plaintiffs... READ MORE

23
Oct
2008

In re Text Messaging Antitrust Litigation, No. 08-C-782 (N.D. Ill.)

Faruqi & Faruqi represents a proposed class of direct purchasers who paid a fee per text message, and who allege that Verizon, AT&T and T-Mobile conspired among themselves and with others to fix the price of these fees.  Plaintiffs allege a conspiracy in violation of § 1 of the Sherman... READ MORE

10
Jul
2008

In re: Wellbutrin XL Antitrust Litigation, No. 08-cv-2431 (E.D. Pa.)

In the Wellbutrin XL case, Faruqi & Faruqi, LLP represents a certified class of direct purchasers of GlaxoSmithKline’s branded antidepressant tablet Wellbutrin XL (extended-release bupropion hydrochloride).  The suit alleges that GSK and its co-conspirator, Biovail (now known as Valeant), engaged in an overarching anticompetitive scheme in order to delay less-expensive... READ MORE

27
May
2008

In re Aftermarket Filters Antitrust Litigation, No. 08-4883 (N.D. Ill.)

Faruqi & Faruqi represents a proposed class of direct purchasers of filters challenging conspiracy to fix prices, in violation of § 1 of the Sherman Act.

17
Mar
2008

F & V Oil Company, Inc., et al v. Reddy Ice Holdings, Inc., et al, No. 08-11152 (E.D. Mich.)

This price fixing case is a product of three packaged ice manufacturers which pleaded guilty to price fixing charges.  Faruqi & Faruqi represents a class of direct purchasers against manufacturers of packaged ice alleging conspiracy to fix prices and allocate markets in violation of § 1 of the Sherman Act. ... READ MORE

12
Mar
2008

In re Chocolate Confectionary Antitrust Litigation, No. 08-MD-1935 (M.D. Pa.)

In re Chocolate Confectionary Antitrust Litigation, No. 08-MD-1935 (M.D. Pa.) (representing some of the largest chain grocery and drug stores challenging conspiracy among the leading chocolate manufacturers to fix prices, in violation of § 1 of the Sherman Act).

11
Mar
2008

In re Pennsylvania Title Ins. Antitrust Litigation, No. 08-1202 (E.D. Pa.)

In the Pennsylvania Title Insurance Antitrust Litigation, Faruqi & Faruqi, LLP represents a class of direct purchasers of title insurance, who allege that title insurers in Pennsylvania utilized a rating agency (called the Title Insurance Rating Bureau of Pennsylvania) to facilitate a cartel and impose illegal cartel pricing on policyholders... READ MORE

31
May
2007

Jimico Enterprises, Inc., et al. v. Lehigh Gas Corp., No. 07-578 (N.D.N.Y.)

In this case involving the operators of gas stations on the New York State Thruway, Faruqi & Faruqi represents several terminated gas stations alleging illegal terminations in violation of the Petroleum Marketing Practices Act.  After partial summary judgment was granted to plaintiffs, a damages hearing was held wherein plaintiffs were... READ MORE

19
Mar
2007

Marchbanks Truck Service, Inc., et al. v. Comdata Network, Inc., et al., No. 07-1078-JKG-HSP (E.D. Pa.)

Faruqi & Faruqi represents a proposed class of independent truck stops against fleet card issuer Comdata and the largest chain truck stops in the United States for abuse of monopoly power and tying and bundling in violation of §§ 1 and 2 of the Sherman Act.  Plaintiffs allege that the... READ MORE

12
Mar
2007

Rochester Drug Co-Operative, Inc., et al. v. Braintree Labs, Inc., No. 07-142 (D. Del.)

In this case, nicknamed the MiraLax case, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a settlement class of direct purchasers of Braintree’s branded drug, MiraLax (polyethylene glycol 3350).  The case alleges that Braintree, to forestall competition from less-expensive generic versions of MiraLax, hatched an anticompetitive scheme that included... READ MORE

05
Jun
2006

In re Metoprolol Succinate Direct Purchaser Antitrust Litigation, No. 06-52 (D. Del.)

In the Toprol case, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a class of direct purchasers of AstraZeneca’s branded drug Toprol XL (extended-release metoprolol succinate).  The case alleges that AstraZeneca fraudulently procured two patents and filed multiple baseless patent infringement lawsuits using those patents, solely in an effort... READ MORE

27
Apr
2006

King Drug Company of Florence, Inc., et al. v. Cephalon, Inc., et al., No. 06-1797 (E.D. Pa.)

In this case, nicknamed Provigil, Faruqi & Faruqi, LLP represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Cephalon’s (now Teva’s) branded wakefulness drug, Provigil (modafinil).  The case alleges that that the brand manufacturer, Cephalon, conspired with 4 generic competitors not to launch their generic versions of... READ MORE

28
Dec
2005

Babyage.com, Inc., et al. v. Toys "R" Us, Inc., No. 05-6792 (E.D. Pa.)

In Babyage.com, Inc., et al. v. Toys “R” Us, Inc., et al., Faruqi & Faruqi, LLP represented three internet retailers of baby products, who challenged a dominant retailer’s anticompetitive scheme, in concert with co-conspirator manufacturers, to impose and enforce resale price maintenance in violation of §§ 1 and 2 of... READ MORE

11
Aug
2005

In re Tricor Antitrust Litigation, No. 05-360 (D. Del.)

Faruqi & Faruqi represented PacifiCare, and other large third-party payors challenging the conduct of Abbott Laboratories and Laboratories Fournier in suppressing generic drug competition, in violation of §§ 1 and 2 of the Sherman Act. The Tricor case settled for undisclosed amount in 2010.

Page 53 of 54 (1062 Items)